High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality

被引：25
作者：
Gordon S. [1 ]
Durairaj A. [1 ]
Lu J.L. [2 ]
Davidson W.S. [1 ]
机构：
[1] Center for Lipid and Arteriosclerosis Science, University of Cincinnati, Cincinnati, OH, 45237-0507
[2] Division of Biomedical Informatics, Cincinnati Children's Hospital Research Foundation, Cincinnati, OH, 45229-3039, 3333 Burnet Avenue
来源：
Current Cardiovascular Risk Reports | 2010年 / 4卷 / 1期
关键词：
Apolipoprotein; Cardiovascular disease; High density lipoprotein; Lipoprotein; Mass spectrometry; Protein; Proteomics; Reverse cholesterol transport;
D O I：
10.1007/s12170-009-0069-9
中图分类号：
学科分类号：
摘要：
Recent proteomics studies on human plasma high-density lipoprotein (HDL) have discovered up to 50 individual protein constituents. Many of these have known functions that vary surprisingly from the lipid transport roles commonly thought to mediate HDL's ability to protect from coronary artery disease. Given newly discovered roles in inflammation, protease inhibition, complement regulation, and innate immunity, many have begun to view HDL as a broad collection of distinct particle subfamilies, each distinguished by unique protein compositions and functions. Herein we review recent applications of high-resolution proteomics to HDL and summarize evidence supporting the idea of HDL functional subspeciation. These studies have set the stage for a more complete understanding of the molecular basis of HDL functional heterogeneity and hold promise for the identification of new biomarkers that can predict disease or evaluate the success of clinical interventions. © 2009 Springer Science+Business Media, LLC.
引用
收藏
页码：1 / 8
页数：7
相关论文
共 45 条
  • [1] Adorni M.P., Zimetti F., Billheimer J.T., Et al., The roles of different pathways in the release of cholesterol from macrophages, J Lipid Res, 48, pp. 2453-2462, (2007)
  • [2] Gu X., Trigatti B., Xu S., Et al., The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain, J Biol Chem, 273, pp. 26338-26348, (1998)
  • [3] Moore R.E., Navab M., Millar J.S., Et al., Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation, Circ Res, 97, pp. 763-771, (2005)
  • [4] Navab M., Hama S.Y., Anantharamaiah G.M., Et al., Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein. Steps 2 and 3, J Lipid Res, 41, pp. 1495-1508, (2000)
  • [5] Barter P.J., Rye K.A., High density lipoproteins and coronary heart disease, Atherosclerosis, 121, pp. 1-12, (1996)
  • [6] Navab M., Imes S.S., Hama S.Y., Et al., Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein, J Clin Invest, 88, pp. 2039-2046, (1991)
  • [7] Puranik R., Bao S., Nobecourt E., Et al., Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo, Atherosclerosis, 196, pp. 240-247, (2008)
  • [8] Rye K.A., Bursill C.A., Lambert G., Et al., The metabolism and anti-atherogenic properties of HDL, J Lipid Res, 50, SUPPL., (2009)
  • [9] Concha M.I., Smith V.J., Castro K., Et al., Apolipoproteins A-I and A-II are potentially important effectors of innate immunity in the teleost fish Cyprinus carpio, Eur J Biochem, 271, pp. 2984-2990, (2004)
  • [10] Cruz D., Watson A.D., Miller C.S., Et al., Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy, J Clin Invest, 118, pp. 2917-2928, (2008)
12345